Avidity Biosciences
RNA
#1843
Rank
โ‚น1.015 T
Marketcap
โ‚น6,576
Share price
-0.29%
Change (1 day)
126.36%
Change (1 year)

Market capitalization of Avidity Biosciences (RNA)

Market cap: โ‚น1.015 Trillion

As of February 2026 Avidity Biosciences has a market cap of โ‚น1.015 Trillion. This makes Avidity Biosciences the world's 1843th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น1.015 T4.12%
2025โ‚น975.63 B216.58%
2024โ‚น308.17 B416.63%
2023โ‚น59.65 B-51.12%
2022โ‚น122.04 B47.09%
2021โ‚น82.97 B18.47%
2020โ‚น70.03 B

End of Day market cap according to different sources

On Feb 4th, 2026 the market cap of Avidity Biosciences was reported to be:

โ‚น990.77 Billion
by Nasdaq info icon info icon
โ‚น1.015 Trillion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
โ‚น13.768 T 1,255.41%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น10.439 T 927.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
โ‚น186.94 B-81.60%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
โ‚น536.57 B-47.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
โ‚น11.99 B-98.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
โ‚น74.23 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
โ‚น988.46 B-2.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
โ‚น278.51 B-72.58%๐Ÿ‡บ๐Ÿ‡ธ USA